BjornevikKMünzCCohenJI, et al. (2022) Longitudinal analysis reveals high prevalence of Epstein–Barr virus associated with multiple sclerosis. Science375(6578): 296–301. DOI: 10.1126/science.abj8222.
3.
BjornevikKMünzCCohenJI, et al. (2023) Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nature News. Available at: www.nature.com/articles/s41582-023-00775-5 (accessed April 2025).
4.
CaiXEbellMHHainesL (2021) Accuracy of signs, symptoms, and hematologic parameters for the diagnosis of infectious mononucleosis: a systematic review and meta-analysis. The Journal of the American Board of Family Medicine34(6): 1141–1156. DOI: 10.3122/jabfm.2021.06.210217.
ChapmanAL (2002) Lesson of the week: abdominal pain in acute infectious mononucleosis. BMJ324(7338): 660–661. DOI: 10.1136/bmj.324.7338.660.
8.
De PaorMO’BrienKFaheyT, et al. (2016) Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database of Systematic Reviews12(12): CD011487. DOI: 10.1002/14651858.cd011487.pub2.
OtsukiTIshizukaKHiroseM, et al. (2022) Hoagland sign in infectious mononucleosis. BMJ Case Reports15(11): e252839. DOI: 10.1136/bcr-2022-252839.
20.
PedersenMAsprustenTTGodangK, et al. (2019) Fatigue in Epstein–Barr virus infected adolescents and healthy controls: A prospective multifactorial association study. Journal of Psychosomatic Research121: 46–59. DOI: 10.1016/j.jpsychores.2019.04.008.
RezkENofalYHHamzehA, et al. (2015) Steroids for symptom control in infectious mononucleosis. Cochrane Database of Systematic Reviews2015(11): CD004402. DOI: 10.1002/14651858.cd004402.pub3.
23.
RobinsonWHYounisSLoveZZ, et al. (2024) Epstein–Barr virus as a potentiator of autoimmune diseases. Nature News. Available at: www.nature.com/articles/s41584-024-01167-9 (accessed 29 April 2025).
24.
RostgaardKBalfourHHJarrettR, et al. (2019) Primary Epstein–Barr virus infection with and without infectious mononucleosis. PLOS ONE14(12): e0226436. DOI: 10.1371/journal.pone.0226436.
25.
SchechterSLampsL (2018) Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Archives of Pathology & Laboratory Medicine142(10): 1191–1195. DOI: 10.5858/arpa.2018-0208-ra.
WeldonEJHongBHayashiJ, et al. (2023) Mechanisms and severity of exercise intolerance following COVID-19 and similar viral infections: a comparative review. Cureus15(5): e39722. DOI: 10.7759/cureus.39722.